Original Article
Multivessel Percutaneous Coronary Interventions in the United States: Insights From the Nationwide Inpatient Sample
Angiology 1-10 ª The Author(s) 2015 Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/0003319715593853 ang.sagepub.com
Shilpkumar Arora, MD1, Sidakpal S. Panaich, MD2, Nileshkumar J. Patel, MD3, Nilay Patel, MD4, Shantanu Solanki, MD5, Abhishek Deshmukh, MD6, Vikas Singh, MD7, Sopan Lahewala, MD8, Chirag Savani, MD9, Badal Thakkar, MD10, Abhishek Dave, MD11, Achint Patel, MD5, Parth Bhatt, MD10, Rajesh Sonani, MD12, Aashay Patel, MD13, Michael Cleman, MD14, John K. Forrest, MD14, Theodore Schreiber, MD2, Apurva O. Badheka, MD, FACP, CCDS14, and Cindy Grines, MD2 Abstract Background: Multivessel coronary artery disease carries significant mortality risk. Comprehensive data on inhospital outcomes following multivessel percutaneous coronary intervention (MVPCI) are sparse. Methods: We queried the Healthcare Cost and Utilization Project’s nationwide inpatient sample (NIS) between 2006 and 2011 using different International Classification of Diseases, 9th Revision, Clinical Modification procedure codes. The primary outcome was inhospital all-cause mortality, and the secondary outcome was a composite of inhospital mortality and periprocedural complications. Results: The overall mortality was low at 0.73% following MVPCI. Multivariate analysis revealed that (odds ratio, 95% confidence interval, P value) age (1.63, 1.48-1.79;
Multivessel Percutaneous Coronary Interventions in the United States: Insights From the Nationwide Inpatient Sample
Angiology 1-10 ª The Author(s) 2015 Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/0003319715593853 ang.sagepub.com
Shilpkumar Arora, MD1, Sidakpal S. Panaich, MD2, Nileshkumar J. Patel, MD3, Nilay Patel, MD4, Shantanu Solanki, MD5, Abhishek Deshmukh, MD6, Vikas Singh, MD7, Sopan Lahewala, MD8, Chirag Savani, MD9, Badal Thakkar, MD10, Abhishek Dave, MD11, Achint Patel, MD5, Parth Bhatt, MD10, Rajesh Sonani, MD12, Aashay Patel, MD13, Michael Cleman, MD14, John K. Forrest, MD14, Theodore Schreiber, MD2, Apurva O. Badheka, MD, FACP, CCDS14, and Cindy Grines, MD2 Abstract Background: Multivessel coronary artery disease carries significant mortality risk. Comprehensive data on inhospital outcomes following multivessel percutaneous coronary intervention (MVPCI) are sparse. Methods: We queried the Healthcare Cost and Utilization Project’s nationwide inpatient sample (NIS) between 2006 and 2011 using different International Classification of Diseases, 9th Revision, Clinical Modification procedure codes. The primary outcome was inhospital all-cause mortality, and the secondary outcome was a composite of inhospital mortality and periprocedural complications. Results: The overall mortality was low at 0.73% following MVPCI. Multivariate analysis revealed that (odds ratio, 95% confidence interval, P value) age (1.63, 1.48-1.79;
